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The quantum physical theory has made the quantitative understanding of pro-
cesses on submicroscopic level possible. This understanding in turn enhanced
greatly possibilities of rational approaches to design materials for technology and
drugs for medicine. Quantum chemistry is the application of quantum mechan-
ics (QM) on the system of interest in chemistry [1], and also in biology, medicine
or material sciences [2]. Quantum chemistry seeks the energy of a system ei-
ther by solving Schrödinger equation, that is applying a Hamilton operator to a
wave function of a system – as in case of wave-function based methods (such as
Hartree-Fock, MP2, CCSD(T) – section 3.1), or by using electron probability
density instead of the wave function – as in case of density functional theory
(DFT) methods (section 3.2). The first quantum chemical methods formulated,
wave-function methods based on purely theoretical grounds are called ab ini-
tio methods [1]. DFT is usually also considered an ab initio method, given
the computational demands and accuracy. These methods require progressively
more time as the system being solved grows larger. For example, Hartree-Fock
method, a cornerstone of quantum chemistry, scales with the fourth power of
the system size [3]. Even though powerful computers are utilized nowadays, the
evaluation of properties of larger molecular complexes is still time consuming
[4].
1.2 Semiempirical Quantum Mechanical Methods (SQM)
SQM methods are approximations to QM (quantum mechanical) methods [3].
By invoking simplifications or neglects of equations in places where the most
time can be saved for the least accuracy detriment, they offer a compromise
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solution for larger systems. While less accurate, they retain their quantum
character and as such they can still provide some description of phenomena such
as charge transfer [3, 5], often important for binding (of protein and ligand,
for example). Although they contain parameters, once they are determined,
the method works universally (given all parameters for elements present in the
system studied are provided). This is in contrast with molecular mechanics
(MM) methods, which require an independent parametrization for each specific
system [6, 7]. These properties along with the computational time savings make
SQM methods suitable for use in in silico drug design [8], as will be discussed
in section 1.6.
Two SQM approaches most prominently used today are those based on
molecular orbital theory – Hartree-Fock (HF) derived methods, such as PM6
and recent PM7, and those based on density functional theory (DFT) – DFTB
density-functional tight-binding methods [3]. These approaches are described
in detail in sections 3.1 and 3.2 respectively.
1.3 Corrections for Non-covalent Interactions
To adjust for the loss of accuracy of SQM methods caused by the simplifications
they apply (or to improve the performance of less advanced QM methods),
corrections can be added to adjust some observed error trends of a method
in question. Corrections for dispersion are illustrative examples. It has been
found out that neither the HF nor DFT account correctly for the dispersion
interaction [9]. Empirical function based on London‘s formula has been used
to reproduce dissociation curves of noble gas complexes, where dispersion is
important. It has terms inversely proportional to the sixth, eight, tenth, etc.
power of the separation of interacting centers [10, 11]. General form of this kind












adds an additive dispersion correction contribution from a multipole n to the
calculated energy for each pair of atoms A and B separated by distance RAB .
f damp is a damping function which turns the correction off for small distances
and s is a global scaling parameter for a given method (functional) [12]. Among
the most used is the Grimme‘s correction proposed originally for DFT [13],
D3. DFT-D3 includes terms for n=6, 8 with parameters in f damp and coor-
dination number dependent C coefficients determined by higher-level methods
(time dependent DFT) [14]. In the most recent version D4, the atomic pair-
wise C coefficients were made dependent on atomic partial charges by means
of a function multiplying atomic polarizabilities (used for the determination of
C in these models). Also, three-body dispersion term addressing nonadditivity
is utilized by default unlike in the model‘s predecessors [15]. Thus a corrective
formula is generally built on a rational basis (London dispersion in this case)
but contains parameters that ensure the best results (compared to a reference)
for a method being corrected [13, 14]. The widespread use of these dispersion-
corrected DFT functionals proves the general usefulness of empirical corrections,
even for higher-level computational methods.
SQM methods, being simplified QM methods, also share the drawbacks of
their respective QM templates, and so they also require adjusting for the disper-
sion interaction. Empirical dispersion correction containing the term decaying
with the sixth power of the atomic separation and with a damping function as in
equation EQ.1 was proposed first for DFTB [16]. The CAB were calculated from
empirically determined atomic polarizabilities and numbers of valence electrons.
Likewise for wave-function-based MNDO – AM1 and PM3 methods, the polariz-
ability (calculated by these methods) dependent dispersion correction has been
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supplied [17]. For PM6, the dispersion correction based on the work of Jurečka
et. al. [18] parametrized together with the hydrogen bond correction (see in the
further text) PM6-DH has been developed in our group. The parameters CAB
were originally taken from ref. [13] and the damping function modified (so that
the sn scaling factor scales van der Waals radii in the damping function rather
than the whole function). Recent versions of the these corrections parametrized
for use with PM6 and DFTB3 methods (section 3.3.1) are widely used.
It has been found out that in addition to the missing dispersion the MNDO
methods failed at the description of hydrogen bonds [19]. Although hydrogen
atom was supplied by additional Gaussian functions to its core-core term in
AM1 [20] and the term was modified also in PM6 [19], the methods still yielded
inaccurate results for hydrogen bonded complexes [21].
The introduction of an additional relatively simple hydrogen correcting em-
pirical term to the SQM method can enhance its accuracy, so it rivals QM
methods [22, 23].
The first of hydrogen bond corrections for SQM methods developed in our
group has been parametrized for the PM6 method along with the D correction
(PM6-DH) [21]. It added an independent energy correction to the several kinds









with a,b and A an interaction specific parameters. The first term is an elec-
trostatic component based on partial atomic charges q, scaled by an angular
part reproducing hydrogen bond directionality. The second term is a correc-
tive repulsive exponential. Subsequent H2 correction paired with D correction
adjusted the D for a SQM method and addressed several interaction-specific
issues [24]. The third variant of the correction H+ abandoned partial charges,
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for which it would be demanding to calculate derivatives and has a form
CX + CY
2r2XY
× fangular × fbond(rZH)× fdamp(rXY ) (EQ.3)
with atom specific parameters C, f angular containing multiple relevant angles,
and two more empirical functions of the interacting atoms separation with Z
being the closer atom of X and Y to the hydrogen. Most recent versions of these
corrections are H4 (D3H4) and H5 (D3H5), with the latter being specific for
DFTB3. These are discussed in Methods in sections 3.3.1 and 3.3.3, respectively.
Halogen bond is a noncovalent interaction, in which an electrophilic (pos-
itive) region on a halogen (X) interacts with a nucleophilic (negative) region
on an interacting partner (Y) in an arrangement Z-X · · · Y. The anisotropy in
charge distribution of the halogen giving rise to the positive region is caused by
an influence of a Z atom, to which it is covalently bonded.
Halogen bond can be important for protein-ligand binding, since common
ligands are often halogenated [7, 25]. SQM methods tend to overestimate this
interaction [26]. For instance, halogen bond corrections X have been devel-
oped for PM6 (for example in PM6-D3H4X), supplying a separation dependent
exponential repulsion to the energy [27].
1.4 Solvation Modelling Approaches for SQM Methods
If the SQM methods are to reliably describe biological systems (such as protein-
ligand complexes – relevant for drug design purposes), the complex environment
of the system has to be considered. The first and likely the most important step
to model this complexity is the inclusion of solvent – water.
The inclusion of water molecules to be calculated explicitly along with a
protein and a ligand would become a bottleneck for in silico drug design which
requires fast evaluation of binding properties – by SQM or still more approx-
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imate methods (section 1.6). Rather than representing solvent as individual
molecules, solvation models treating the solvent as a continuum are employed
with SQM methods for effective description of larger systems. The solvation
(free) energy ∆Gsol is then the change in energy that accompanies the trans-
fer of a compound from vacuum to water, the difference of energies in vacuum
and in solvent. The energy in vacuum can be provided by electronic struc-
ture method and the solvation energy is supplied by the solvation model, which
is used in conjunction with the electronic structure method. The influence of
the solvent can be separated into polar and nonpolar terms. The latter tradi-
tionally features dispersion, cavitation and repulsion energy. There are many
approaches for expressing each of these contributions [28]. An example of a





the sum of solvent-accessible surface of each atom type multiplied by an atom-
specific constant. Among approaches broadly used today accounting for solvent
polar influence are apparent surface charge (ASC) methods, multipole expan-
sion and generalized Born methods (GB). In generalized Born methods, solute
is represented by point charges i and j at the nuclei and the electrostatic con-












where the f GB is an effective function of a separation between charges and
atomic radii. The nonpolar contribution is traditionally expressed as EQ.4 in
GB model [29]. Multipole expansion models extend GB approach from point
charges (monopoles) to higher-order (multipoles).
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In ASC, the potential due to the solute polarization of the solvent is a po-
tential at the point r given by a number of charges Q placed at the surface of







Where the apparent surface charge Q is calculated from the overall potential in
the cavity as a sum of a solute potential Vsolute given by the electronic structure
of a solute calculated by a method of choice and a potential of polarized solvent




Sa∇(Vsolute + Vinside,σ) (EQ.7)
Where Sa is a surface area ascribed to the charge a, ϵ is the permittivity of the
medium. As the potential depends on its own value in the cavity, the evaluation
is iterative [1, 28]. Among most broadly used models to use with SQM are
PCM, COSMO and SMD.
1.5 Parametrization of SQM Methods
As was alluded to in previous sections, parameters in the empirical corrections
can be derived by fitting the proposed mathematical form, correction function,
to reference data (benchmark). The set of data for fitting a quantity, such as
energy, consists of series of molecular geometries with corresponding benchmark
quantity (such as energy) values and is thus called benchmark dataset. Bench-
mark dataset used for this purpose of obtaining parameters for a method or its
corrections is a "training dataset" (method/correction is being trained). Prior
to the parametrization, data sets can be used to study systematic deviations
among methods, so that the proper form of a correcting term can be designed,
12
or to test the performance of methods.
Obviously, having the best possible reference benchmark for the parametriza-
tion of correction forms is highly advantageous. In case when the experimental
data is unavailable or unreliable, high-level computations are often resorted to.
An interesting aspect of the parametrization against a reference is that param-
eters absorb all the difference between the reference data and the output of
method being corrected, including high-level energy corrections, irrespective of
a physical basis of the difference.
The benchmark dataset should be large and diverse, so that various trends
in deviations of methods can be studied, captured and corrected for. If the
dataset consisted only of a limited variety of system kinds, not all the subtle
physical phenomena would be traceable and the outcomes may not necessarily
be transferable to other systems. In practice, it is necessary only to cover in the
dataset the kind of systems, that the methods will be used on. For use of SQM
or QM methods in in silico drug design, those are systems featuring proteins,
their ligands, nucleic acids or other biomolecules but most often protein-ligand
complexes. The vast majority of medically relevant proteins consist of 20 amino
acids, most often built from only 5 elements (H, C, N, O, S). However, due to
their polymer nature, their 3-dimensional structure is very diverse. Although
low-molecular-weight drugs that bind to them are chemically more variable,
there are general patterns of their composition, too.
1.6 In Silico Drug Design
In the field of drug design, the aim is to find and optimize a compound (drug)
that interacts with the target biomolecule, thus curing or at least treating a
disease. In silico drug design uses computers to achieve this goal. There is
a great diversity of approaches and they can be combined in various ways.
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Because of this diversity, only a brief overview is presented in this section. The
approaches fall into ligand- or structure-based methods, depending on whether
a 3D structure of the target protein is absent or present, respectively.
In ligand-based methods, a drug candidate may be devised based on the
descriptors of other compounds that bind the target by using quantitative
structure-activity relationship (QSAR) or pharmacophore models [30].
Structure-based approaches attempt at finding compounds which would bind
to a target protein of known structure from a database of small molecules,
putative ligands. This process is called virtual (i.e. computer-aided) screening
and consists of two key steps: docking and scoring. Docking algorithms fit
the compound to the target protein and scoring functions than estimate how
strongly does the docked compound bind. The strongly binding compound
found by this approach is then presumably a strong ligand of the target protein
– a drug.
In structure-based approaches, the target structures are obtained from exper-
iments (X-ray crystallography, nuclear magnetic resonance) or homology mod-
elling. Protein Data Bank (PDB) is a freely accessible repository containing
hundreds of thousands of biomolecular structures. PDB was the source of struc-
tures for the construction of datasets in the Dataset part of this work (section
5).
Scoring functions can be classified as those using statistical thermodynam-
ics, as empirical, knowledge-based or physics-based. Physics-based describe
individual interactions either by force fields (Newtonian forces, as in molecular
dynamics) or by quantum chemical means. The latter can be SQM or ab initio
QM, in most advanced approaches [6, 30, 31].
In empirical scoring functions a few of additive descriptors of a system (such
as number of hydrogen bonds) can be used to produce a quantity that reflects
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the ligand affinity to a protein (score). The terms in the function are proposed
and then the weights of the term contributions have to be determined by fitting
to the reference values of complexes with known affinities – the training datasets.
Knowledge-based scoring functions work in a similar way, but in this case, from
larger training sets more general principles can be derived. Frequency of occur-
rence of some of many possible properties or descriptors (such as distance of
two specific atom types) among strong binders can be used to derive potential
function. In that sense knowledge-based scoring functions are more empirical
than above mentioned empirical scoring functions [30]. Recently, artificial in-
telligence and machine learning algorithms are utilized for the identification of
drug candidates, for example in scoring function development [31].
Scoring functions mentioned in the latter paragraph do, however, not pro-
vide good estimates of active ligands consistently for different proteins. The
quantum-mechanical based (SQM) scoring functions outperform these other
scoring functions substantially [32]. SQM scoring functions are described in
greater detail in the section 1.7.
Testing constituents of entire databases, which may contain more than 107
[33] molecules, by means of virtual screening requires great number of compu-
tations (as many as 1013 [34]). Thus, when taking the size of the system (few
thousands of atoms) into account, the use of ab initio QM methods is impracti-
cal in this case [35, 36]. Nevertheless, several QM-based scoring functions have
been developed [37] and can be used for smaller-scale applications, with a frag-
mentation scheme or within a QM/MM setup, for instance (next paragraph).
Even though QM ab initio methods are usually too demanding to be used
on large systems (such as whole proteins) in in silico drug design, SQM meth-
ods are a viable alternative. Fragmentation approaches can be used to further
increase the efficiency of SQM or QM methods for large systems. In such ap-
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proaches a large molecule is fragmented into smaller subsystems and the energy
of a molecule is taken as a sum of energies of individual fragments [4, 38]. This
approach neglects nonlinear effects (such as polarization among fragments), but
it is possible to include these missing effects in some approximate way – for
example, on a lower level of theory [39]. Another approach related to the frag-
mentation strategy can be used in case the system of interest is too large for
a given higher-lever method: the higher-level method is applied on the ligand
and its immediate environment and a lower-level method on the reminder of the
molecule. An ab initio QM method can be a higher-lever method and a SQM a
lower-level one [37] or molecular mechanics or SQM can be a lower-level method
for a QM/MM, SQM/MM setups, respectively [40, 41]
The strength of the binding can be expressed as an interaction energy, the
difference of energies of a complex (in in silico drug design most often ligand-
protein complex) and the energies of its constituents (Fig. 1.6). The interaction
energy can be used as a score or a score component [42]. Taking the interac-
tion energy alone as a score would neglect the (presumably) subtle structural
rearrangements upon binding – relaxation energy, which has to be accounted
for in case of highly mobile structures. The force-field (molecular mechanics) or
electronic structure SQM methods can provide an energy of a system in a single
calculation. A similar important quantity is the change of solvation free energy
upon the complexation ∆∆Gsolv , the difference between the solvation energies
of a complex and its isolated constituents (protein and ligand). It corresponds
to the change of free energy upon binding due to the solvent and it is also used in
SQM scoring functions and will be referred to as "interaction solvation energy"
further.
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Figure 1: An interaction energy as a difference of energies of a complex (protein-
ligand) and energies of individual protein and ligand respectively. Here, HIV
protease and its ligand of Protein Data Bank code 1ztz [43] has been used for
an illustration. The isolated monomers are extracted from the complex for
the interaction energy calculation without a relaxation of geometry. Missing
deformation contributions are neglected or considered independently (section
1.7)
1.7 Applications of SQM Methods to in Silico Drug De-
sign
For the statistical thermodynamical approach mentioned in section 1.6, QM [44]
or SQM [45] methods have been used in QM/MM setups. QM/MM (usually
meaning SQM in this context, as was used in the reference [41]) have been
used to enhance the quality of a docked complex and DFT has been used in the
context of QM/MM for proteins, too [40, 46]. AM1 has been used alongside with
COSMO with MOZYME linear scaling algorithm (section 3.3.4) to evaluate the
correlation of calculated interaction energies with the experimental affinities
[47]. The authors argued that flawed accuracy is largely due to COSMO not
being parametrized for biomolecules (RNA-ligand complexes were investigated
in this study). The first SQM scoring function per se introduced a physically
sound score for a protein ligand complex of a form
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score = Hbind + Edisp +∆∆Gsolv − T∆S (EQ.8)
With the change of solvation energy ∆∆Gsolv being estimated at the Poisson-
Boltzmann model (a generalization to the Generalized Born models) [48]. The
H bind interaction energy was calculated at the AM1 level and was augmented by
an attractive part of a Lennard-Jones potential (the Edisp term decaying with
the sixth power of atom-atom separation – as in equation EQ.1). An entropy
term was introduced to this score with ∆S being the sum of a linear function
of rotatable bonds immobilised upon binding and a term corresponding to the
change of a solvent-exposed surface by a complex formation. This SQM scoring
function performed better than 11 other non-QM-based scoring functions tested
in the study on metalloprotein complexes. As quantum effects are important
in active sites of such complexes (charge transfer involving metalloprotein en-
zyme and its metal cofactor), the use of QM-based methods was appropriate.
Molecular-orbital-based SQM methods (section 3.1) used in several studies of
protein ligand complexes included PM6-DH2, PM6-D3, PM6-D+, and also PM7
with the implication of their usage in virtual screening [49–51]. Scoring func-
tions featuring DFTB (section 3.2) energy have also been used in this context,
to optimize the docked structures [52].
The SQM scoring function developed in our group before has a similar gen-
eral form as in equation EQ.8
score = Ebind +∆∆Gsolv +Gconf − T∆S (EQ.9)
but with the interaction energy E int calculated on the PM6-D3H4X level, and
with the solvation contribution ∆∆Gsolv calculated with the SMD or COSMO
models. The conformational energy Gconf is the energy change associated with
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the change of conformation of a protein and a ligand upon the binding. To cap-
ture this effect, energy minimisation of both interacting partners isolated from
the geometry of the complex as a starting point has to be done. The last term of
equation EQ.9 can be obtained from the number of rotatable bonds of complex
and constituents or from their calculated vibrational energy levels [53]. This
scoring function was then simplified to include only interaction and solvation
interaction energies. Together with some other adjustments in the preparation
of the systems, the procedure ran much faster, while still being efficient for sys-
tems tested [54]. Later, another variant of this scoring function was introduced,
in which the PM6 D3H4X in the interaction energy term was swapped for the
DFTB3 D3H4 as an SQM method of choice. This was done to address the
difficulties encountered when treating metalloproteins [55]. Recently, COSMO2
[56] has been implemented into this scoring functions in place of solvation model
[42].
2 Aim of the Thesis
The aim of this thesis is to optimize the efficiency of semiempirical quantum me-
chanical (SQM) methods by means of empirical corrections for their utilization
in computer-aided drug design.
In the first part of the thesis we describe the reparametrization of the implicit
solvation model COSMO along with the addition of a term corresponding to
nonpolar contributions. The resultant optimized model is designated COSMO2
(published as reference [56], provided as appendix A)). This optimized model
is to become a part of scoring function developed in our group to improve the
performance of a solvation model as a scoring function accuracy limiting factor.
The subject of the second part of the thesis is the construction of protein-
ligand derived datasets of noncovalent interactions for testing the accuracy and
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development of SQM methods, PLF547 and PLA15. The PLF547 dataset con-
sists of fragments of protein interacting with ligands and the PLA15 is a dataset
of protein active sites complexed with ligands. By constructing of these datasets,
we are addressing the lack of quality reference data suitable specifically for the
drug design applications (benchmark data on protein-ligand complexes). The
accuracy of selected methods, including COSMO2, is tested on the newly de-
veloped PLF547 and PLA15 datasets. The results of this part are published as
reference [23] and are provided as appendix B).
3 Methods
3.1 Molecular-Orbital-Based SQM Methods
Molecular-orbital-based (wave-function-based) semiempirical methods are akin
to HF method in the basic formulation of the problem and can be regarded
as its simplification. In this basic formulation a molecular orbital is expressed
as a linear combination of atomic orbitals χ (i.e. functions of space centered
on atom). The analytically unsolvable two-electron part of Hamiltonian is re-
garded as an interaction of each electron with a potential formed by a "static"
electronic distribution of all the other electrons residing in their respective χ.
The composition of molecular orbital from χ of various weights is guessed so it
can be substituted for the electron distribution which appears in a two-electron
Hamiltonian in addition to being a function on which an operator operates,
yielding the energy and improved composition of molecular orbital. This new
composition (a wave function) is then used again in an iterative procedure un-
til a state is reached in which a substituted function yields (within a specific
threshold) itself – a self consistency is reached. The method is also called self-
consistent field (SCF). Each successive step represents a reaction of electrons to
20



















































Where the first one-electron integral represents a kinetic energy of an electron
and an energy of its interaction with nuclei A. Second integral over coordinates
of pair of electrons represents Coulomb and exchange interactions between elec-
trons. The sums r, s, t and u goes over b basis functions χ, the sum i and j
goes over n/2 spatial molecular orbitals. The last term stands for the pairwise
interaction of N nuclei of charges Z.
HF derived molecular-orbital-based SQM methods aside other approxima-
tions neglect some of two-electron integrals, which leads to a considerable com-
putational time savings. The types of omitted integrals gives the basic definition
of the method. Various extensions of this basic definition can vary in the differ-
ent parameter sets or in empirical functions used.
Historically, among the most important molecular-orbital SQM methods
were complete neglect of differential overlap (CNDO), intermediate neglect of
differential overlap (INDO) alleviating the neglect of some integrals, neglect of
diatomic differential overlap (NDDO) further increasing the range of integrals
and modified neglect of differential overlap (MNDO). A further extension of
MNDO leads to Austin model 1 (AM1), Parametrized model 3 (PM3), 6 (PM6)
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and latest PM7. For all the methods, only the valence electrons are treated,
while the rest is included in the potential due to the nucleus, forming an effective
core potential which is invariant under the SCF procedure.
The starting point for SQM methods was the CNDO. CNDO neglected two-
electron integrals (both integrals over ν1 and ν2) other than those with both
basis functions χ over one electron being equal (χr(1) equals χs(1)), and likewise
for the second electron. INDO included also integrals in which all the basis
functions χ were located on the same atom [3].
NDDO and derived more recent methods include all two-electron integrals
with both basis functions of first electron (such as χr(1) and χs(1) in the first
integral) on the same atom, and both basis functions of second electron likewise
are on the same atom. These remaining not neglected integrals are replaced by
approximate expressions which include parameters that are fitted to reproduce
benchmark results or conform with experimental data. For instance, NDDO
remaining two-electron integrals are approximated as γrs
γrs =
1









And likewise for γss . The integral γrr or γss can be taken as the difference
between the ionization potential and the electron affinity of element on which
the basis function χr is localized. [57, 58]























for both basis functions centered on atom A. The first integral is neglected
for χr not being equal χs and is often parametrized as an average of ionization
potential and electron affinity of an atom A otherwise [59, 60]. SB is a spherical
core density on B of electrons that have been left out by the valence treatment.
And for basis functions centered on different atoms the one-electron (reso-







Where βArBs is approximated as an average of β parameters for different
types of atoms and is scaled by an overlap integral [59]. Above described neglec-
tions of integrals employed by NDDO and derived methods reduce the number
of integrals to the second power of the basis. The diagonalization of the matrix
elements to calculate the energy (property) then scales with the third power of
the system size (basis functions), which is thus the bottleneck of the method
regarding its speed [3, 61].












dν1ν2 + fAB (EQ.15)
Where C are charges on nuclei A and B modified by the core electrons on those
nuclei. The fAB is the empirical function of interatomic distance containing
atom-specific parameter.
MNDO represents a further step in the SQM molecular orbital method de-
velopment. The integrals of MNDO represent same interactions as in NDDO,



























Where i and j are point charges of respective multipoles separated by R, ρA
and ρB are density-like additive terms characteristic for each atom type A and
B of a given l. These with the distances of a point charge of a multipole from
a nucleus center are atom parameters obtained from other quantities accessible
from the calculation. MNDO is the basis of currently used molecular orbital
SQM methods in that these subsequent methods retain this MNDO form of
integrals [62].
For the AM1 and PM methods, MNDO parameters are reoptimized and the
form of f AB is readjusted. PM6 also extends a basis set to d orbitals for selected
heavier elements [63]. PM7 augmented integrals with empirical functions mainly
correcting description of solids and added empirical dispersion and hydrogen
bond corrections [64]. PM6 and PM7 will be further elaborated in the sections
3.3.1 and 3.3.2.
3.2 Density-Functional Tight-Binding Methods
The second major family of SQM methods is density-functional-theory (DFT)
based. DFT uses electron probability density rather than a wave function, as
is the case in HF, to derive desired properties of a system. In present practice,
(Kohn-Sham) orbitals are reintroduced to construct a density. The orbitals are
used to calculate the interaction of electron with nuclei, electronic kinetic energy




























dν1dν2 + Exc(ρ) (EQ.18)
The molecular orbitals θ are then expanded as a linear combination of atomic
orbitals, yielding comparable terms as in EQ.10. The quantity of sum over
squares of molecular orbitals θ represents an electron density, which is used in a
EXC exchange correlation functional. Its correlation part is designed to correct
the error due to the approximation of "static" electronic distribution creating a
potential for each individual electron in each successive SCF step. The exchange
part is meant to describe the Fermi effects of like-spin fermions. This last term
effectively covers all the rest to the energy, except for relatively easily attainable
effects described by the first three terms [1].
SQM methods derived from DFT are density functional tight-binding meth-
ods (DFTB). DFTB is formulated around the Taylor expansion of density




























Where the first term, sometimes also zeroth order correction to the reference,
represents a repulsion potential. This potential between reference densities of
atoms A and B is a function fitted to adjust for the energy difference between
the DFTB and a reliable high-level computational method [65]. Thereby it
also absorbs some portion of an error introduced by other terms. The second
term in the equation contains Hamiltonian matrix of basis functions µ and ν
of superposition of densities belonging to neutral free atoms. Integrals for this
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term are precalculated [66]. The expansion coefficients c of these neutral ith
molecular orbitals µ are on atom A and ν on atom B (basis set is minimal).
The ∆q in the third term of the expression EQ.19 represents the interaction of
excess charges on atoms A and B obtained from Mulliken population analysis
of the molecular orbitals. The γ function substitutes for the integral of excess
density over volumes of respective atoms and has the form
1
RAB
− S(RAB ;UA;UB) (EQ.20)
with S being an exponential function where Hubbard parameters U for
atoms are related to the difference of ionization potential and electron affinity
of the respective atom. The γ converges to this difference for no separation and
converges to its first term for large separation RAB [2, 67, 68]
The fourth term, third order correction (thus DFTB3), captures the devia-
tion from the reference density due to the interaction of charged species. ΓAB
features a dependence of γAB function on the excess charge on A [66].
3.3 Computational SQM and QM Methods Tested
DFTB3 and PM6 are SQM methods used in scoring functions developed in
our group [42, 55]. Their significant advantage over some other SQM is an
available implementation with linear scaling algorithms, reducing the speed of
the calculations, so that they can be used efficiently in in silico drug design [42].
Previously the focus in our group has been on the optimization of these methods
and corrections to dispersion, hydrogen and halogen bonds have been developed,
parametrized for them [18, 22]. COSMO is our preferred solvation model, as it
is also available with a linear scaling algorithm, while being sufficiently accurate.
We augment and reparametrize COSMO for the use with PM6 and PM7 in
the COSMO2 part of the thesis. Along with COSMO with original settings and
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newly optimized COSMO2, we test SMD and PCM solvation models in various
computational setups on the reference datasets of solvation energies. We include
higher-level DFT/COSMO-RS results for the comparison with SQM coupled
solvation models.
In the second part of the thesis devoted to the construction of datasets, we
compare the performance of SQM or QM methods potentially suited for in silico
drug design. Aside from DFTB4-D3H4 and PM6-D3H4, also DFTB3-D3H5,
PM7, GFN2-xTB, HF-3C (a QM method) are tested on the datasets constructed
for this part of the thesis. We include older AM1 and PM6 without corrections,
as well as QM DFT with selected functionals and MP2 for comparison. As a
benchmark for the two datasets constructed, we use composite schemes based on
high-level ab initio methods – CCSD(T), MP2 and DFT. We also use COSMO-
RS as a reference for solvation energies, since no experimental data is available
for PLF547 dataset. For PLA15, we use a sum of COSMO-RS solvation energies
as an approximation to the solvation energy of a respective protein active site.
3.3.1 PM6-D3H4 and DFTB3-D3H4
The PM6 is a wave-function-based SQM method derived from MNDO as men-


















with x and α being the pairwise atomic parameters. The function was
slightly augmented for H-O, H-N, C-C and Si-O interactions. A repulsion func-













Later, the two-electron integral of equation EQ.11 was modified slightly to re-
produce properties of solids more accurately [69]. Altogether, PM6 contains
parameters for the first terms introduced in equation EQ.13, β of equation
EQ.14, parameters for two-center electronic interaction of equation EQ.11, or-
bital exponents of basis functions and parameters in core-core functions (some
of which are pairwise). In PM6 the parameters were optimized to reproduce
heats of formation of about 9000 compounds [19, 62].
D3 and H4 corrections in PM6-D3H4 stand for the dispersion correction
and hydrogen bond correction respectively, parametrized for the method, both
adding a post-SCF term to the energy. The dispersion correction D3 is built
upon the D correction (section 1.3). The coefficients CAB of eq. EQ.1 are
calculated for each atom pair and are valence state-specific. The dispersion
term has a form as in EQ.1, only without higher than n=6 terms and it includes
a corrective function for overly attractive hydrogen atoms (including hydrogen
atoms not involved in hydrogen bonds) [22].
The hydrogen bond correction H4 is a product of five functions, which con-
tain geometry arguments and empirical parameters, accounting for: a radial
dependence (polynomial of a donor-acceptor distance), an angular dependence
(donor-hydrogen-acceptor angle), an occasional proton transfer, the charge of
interacting moieties and a function correcting for hydrogen bonds involving wa-
ter which behaves slightly anomalously in PM6 method. The parameters for
the H4 correction along with the parameters of the dispersion correction EQ.1
have been attained by the fit to the reference data of S66 benchmark dataset
(a dataset of small organic molecules interacting with one another in several
orientations and separations) [70, 71].
The D3H4 corrections for DFTB3 are derived in the same way and on the
same benchmark as for PM6, only with the DFTB3 method-characteristic pa-
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rameters.The correction has been parametrized for several other methods [22].
For the DFTB3, we use the 3OB parameters set [65].
3.3.2 PM7
PM7 is the successor of the PM6 method. The authors have, as in case of
PM6, introduced modifications for the integral over two electrons in order to fix
the description of large solid systems. PM7 uses in-built post-SCF dispersion
and hydrogen bond corrections. The dispersion correction has the same general
form as in equation EQ.1, limiting n to 6 [72] and with a slight modification for
solids. Its hydrogen bond correction has a form
CAB
R2AB
× fdamp × fgeom (EQ.23)
where f geom is a function involving goniometric dependences on dihedral angles
and f damp dampens the correction for small and large separations. Unlike PM6-
D3H4, both dispersion and hydrogen bond corrections have been parametrized
along with the rest of PM7 on multiple kinds of reference data which besides
noncovalent interactions also included heats of formation and geometries. This,
according to authors of PM7 publication (ref. [64]), might have been the reason
why PM7 underperformed when tested for noncovalent interactions compared
to variants of dispersion and hydrogen bond corrected PM6, predecessors to
PM6-D3H4 – which were parametrized on datasets for noncovalent interactions
only.
3.3.3 DFTB-D3H5
The hydrogen (H5) part of D3H5 correction to the DFTB3 correcting the hy-










where k is an atom-specific parameter, r0 corresponds to the equilibrium bond
length and together with w are based on van der Waals radii.
This correction multiplies the γAB in the third term of the function EQ.19
for the interactions classed as hydrogen bonds by a Gaussian function centered
at the equilibrium distance for a given hydrogen bond. This enhances the γ
around the distances relevant for the hydrogen bond. The modification of the
γ function directly involves the correction in the self-consistent iterative proce-
dure. DFTB3-D3H5 has also been parametrized on the S66 dataset [71].
3.3.4 Linear Scaling Algorithms, MOZYME
Standard solving (diagonalization) of the Fock matrix has to deal with integrals
where the first electron is in one orbital and the second electron in one each
of all the other orbitals regardless of distance between their respective atom
centers. Resulting molecular orbitals are delocalized. Alternatively, localized
molecular orbitals can be used, limiting the integrals to centers that are close.
Scaling can be made linear with the system size. By MOZYME, interaction of
higher-order multipoles were considered only up to certain separation, lower-
order multipoles were included up to greater separation and the interaction of
monopoles was retained [61].
In DFTB3, similar Divide and Conquer algorithm [73] is available in which
the electron density is partitioned into smaller regions of space calculated in-




GFN-xTB (geometry, frequency, noncovalent interactions, extended tight bind-
ing) is a method akin to DFTB3. While being semiempirical, it employs addi-
tional basis function on hydrogen (double zeta H) and d orbital basis to each of
selected heavier elements. The method uses D3 dispersion correction (section
1.3) and a Lennard-Jones potential resembling form of halogen bond correction
multiplied by an angular damping function [74].
Its successor, GFN2-xTB has no need for an additional basis function on hy-
drogen or an empirical halogen correction. Instead, GFN2-xTB extends DFTB-
level of description by including multipoles (monopole-dipole, dipole-dipole and
monopole-quadrupole interactions) to the charge fluctuation term (third term
of EQ.19 plus corresponding exchange-correlation term) [75]. The method uses
more recent D4 dispersion correction (section 1.3).
3.3.6 HF-3C
HF-3C is a HF method, so it qualifies as a QM method, but it has been pro-
posed as an alternative for SQM when feasible. The method operates with an
individualized small basis set, minimal for H and first row elements other than
Li, Be. Along with D3, it contains other two empirical corrections to the energy
– a basis set superposition correction and a short-range correction. Basis set
superposition error arises from the different basis set sizes of a complex and its
constituents, and gets smaller with increasing basis set. The correction for this
error in HF-3C is a sum over all the atom pairs A-B of basis set dependent
energy differences of atom A multiplied by an exponential function of distance
between A and B scaled by a function of number of virtual (unoccupied) or-
bitals on atom B. The other correction is a core-core augmenting term, also
an exponential of an interatomic separation. The latter corrects specific bond
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lengths [76].
3.4 Quantum Mechanical Benchmark Methods
In the Dataset part we were in a need of reliable benchmark energies for protein-
ligand fragments and for large protein active site complexes. MP2 – second
order of Møller-Plesset perturbation theory and CCSD(T) – coupled clusters
singles, doubles, perturbative triples are high-level QM wave function methods
which incorporate excited Slater determinants to capture the correlation energy
missed out by the SCF treatment. The full CCSD(T) method would have been
too demanding when used on systems of either PLA15 or PLF547 datasets.
The DLPNO-CCSD(T) scheme, which we used instead, allows CCSD(T) to
be applied to larger systems by neglecting contributions from weakly interact-
ing electron pairs (such as distant electrons) to the correlation energy [4]. It
has been shown, that the DLPNO-CCSD(T) in cc-pVTZ with the "tight" en-
ergy threshold for the integral neglection set, the methods reaches about 0.06
kcal/mol standard deviation with errors below 0.25 kcal/mol [4] for the S66
benchmark dataset [71] as compared to the full CCSD(T) in TZ basis. Simi-
larly good agreement has been found between the results of canonical CCSD(T)
and DLPNO in DZ basis on the large GMTKN55 set of molecules (with above






∆CCSD(T )aug−cc−pV DZ = DLPNO CCSD(T )−MP2 (EQ.25)
with MP2F12 being an explicitly correlated method providing a good esti-
mate of MP2 complete basis set (CBS) energy [78] and ∆CCSDT providing the
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correlation energy above the MP2 level (up to DLPNO-CCSD(T)). We have
used aug-cc-pVDZ basis set with the "tight" threshold for DLPNO-CCSD(T),
cc-pVDZ-F12 for MP2-F12 and aug-cc-pVDZ for MP2.
For PLF547, we also provide results by a few QM methods for the com-
parison to the SQM performances: B3LYP/def2-QZVP, BLYP/def2-QZVP and
BLYP/DZVP-DFT, all with D3 correction, and also MP2 in setup used for the
benchmark calculation.
As benchmark solvation energies, we have used COSMO-RS (further section)
and we included also SMD at HF/6-31G* level as an alternative QM-based
solvation model for comparison. In the COSMO2 part, where the experimental
solvation energies were accessible, we used COSMO-RS for comparison.
For the PLA15 dataset of large active site and ligand complexes such an
approach would not have been computationally feasible, still. Instead, we cal-
culated the complex on the DFT (B3LYP-D3/DZVP-DFT) level and added a
correction to the DFT result. The correction was the difference between the
DFT interaction energy of each ith fragment of PLF547 constituting the active
site of PLA15 complex in the same B3LYP-D3/DZVP-DFT setup and the above






(∆EBenchmarki −∆EDFT−D3i ). (EQ.26)
This correlation represents an additive, "unpolarizable" part of a correlation
energy (up to the MP2-F12 – DLPNO-CCSD(T) level) to the DFT, while the
nonlinear effects are covered on the lower DFT level. The non-additive portion
of the correlation energy has been neglected.
For the PLA15 dataset, reference solvation interaction energies of each active
site were approximated by a sum of fragment COSMO-RS energies, since active-
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site COSMO-RS is likewise not feasible. This is presumably a crude measure
which neglects all nonlinear effects.
3.5 Solvation Models
3.5.1 COSMO
COSMO (conductor-like screening model) is an apparent surface charge (ASC)
solvent model (section 1.4). The permittivity constant ϵ is set to ∞ in COSMO,





restituting a dielectric behaviour, where the k is 0.5 for neutral compounds, 0 for
ions [79]. Up to present, COSMO imlpementation for SQM methods has been
lacking a non-polar term, a term covering effects other than those of electrostatic
nature described by ASC formulation.
An essential part of an ASC solvation model is a construction of a cavity
around a solute on which the apparent surface charges are placed. In the original
implementation, the cavity was constructed as an superposition of overlapping
atom-centered spheres of radii close to van der Waals radii (the technical con-
struction was done in a numerical algorithm by projecting surface segments on
the spheres). The cusps resulting from overlapping spheres were then eliminated
by projecting of sphere segments on a larger sphere (extended by the solvent
radius), discarding internal segments and projecting back, leaving holes in a
regions around would-be cusps. In later implementations, holes are filled by
interlocked triangles in various algorithms [80]. The models described further
on use similar cavity construction schemes designed to represent closely molec-
ular shape [79]. The original COSMO implementation uses van der Waals radii
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for the cavity construction, [81] later implementations, however, use optimized
radii, as COSMO-RS does, as well as more elaborate algorithm of cavity con-
struction [80, 82]. The way how the problematic parts of the cavity are handled
(cusps or holes) together with the selection atomic radii are crucial, because the
shape of the cavity impacts the accuracy and robustness of the method.
Figure 2: A cavity built from surface segments by COSMO in the recent
MOPAC implementation around a toluene molecule. Provided by A. Klamt.
3.5.2 COSMO-RS
The continuum solvation model is an approximation, less adequate for a polar
solvent of anisotropic electron density. Important specific interaction like hydro-
gen bonds are also not addressed by the basic model. COSMO-RS (COSMO for
real solvents) builds on the COSMO with DFT calculation. It adds a dispersion
term proportional to the exposed surface area of each atom constituting a solute
multiplied by an atom-specific constant. Similarly, the model takes into account
solute-solute and hydrogen bond interactions by using surface segment charge
densities and the contact areas. These contributions are included by means of
35
statistical thermodynamics [82, 83].
We used B-P/def2-TZVPD DFT to provide the electronic structure of the
solute for COSMO-RS. The COSMO-RS has been used for the benchmark solva-
tion interaction energy of PLF547 and PLA15 datasets and as a reference higher-
level method to the results of other solvation models when testing COSMO2.
3.5.3 PCM
PCM (Polarizable Continuum Model) was historically the first implementation
of ASC solvation models as D- (dielectric) PCM. In a conductor-like PCM vari-
ant C-PCM, infinite ϵ is used, using the same form of a scaling function as
in EQ.27, so that the electrostatic contribution is the same as in COSMO. In
C-PCM, the k is chosen to be 0 [84], as has been recommended by COSMO
authors for ions [82].
Additionally to electrostatic term, PCM contains cavitation, repulsion and






with S i being the area of a surface fragment i from which the cavity is con-
structed, Ri is a radius of a sphere belonging to the fragment i and f is a
function of Ri , solvent radius, solvent density number, pressure and tempera-
















Here, ρ is the solvent number density, RMi a distance between solute atom
M and surface fragment i, RMl between solute atom and a center of sphere
associated with surface fragment i. A repulsion energy is represented by a
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similar, but positive, term featuring exponential function of RMi and expression
of first, second and third power of RMi rather than sixth.
3.5.4 SMD
SMD (Solvation Model Density), unlike to its Generalized-Born-based predeces-
sors, also belongs to the ASC approaches [86] and its formulation is similar to






with ξk being the atomic surface tension dependent on an atomic number and
solvent characteristics, ξM being the solvent characteristics dependent molecular
surface tension and A being the solvent accessible surface area of an atom con-
structed from different radii than those used for the electrostatic contribution
[86].
3.6 Software
PM6 and PM7 methods were used in this work as available in MOPAC 2016
[87], except for the PM6/PCM and PM6/SMD in the COSMO2 part, which were
calculated in GAUSSIAN 09 [88]. HF/6-31G* paired with SMD was used also
in GAUSSIAN in the Dataset part for comparison with SQM-paired solvent
models. PM6 predecessor AM1, tested in COSMO2 part for the comparison
with newer methods, was also used with MOPAC. In the Dataset contribution,
DFTB3 calculations (including DFTB3-D3H5, in the further sections) were per-
formed in DFTB+ code [89]. In the COSMO2 part, the DFTB3 was used in
conjunction with PCM (for which we included a setup with nonpolar term ex-
cluded – denoted C-PCM’ further) and SMD solvation models in GAMESS [90].
GFN-xTB methods use their own code written by the authors of the methods
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– xtb code [74, 75]. We used HF-3C as was implemented with default settings
in ORCA code [91]. All the DFT and MP2 calculations were performed in
TURBOMOLE 7.3 [92]. DLPNO-CCSD(T) calculations were done in ORCA.
COSMO-RS was used in COSMOTHERM-v17 [93].
3.7 Cuby4
Cuby in an integrative platform for computational chemistry [94]. It can be
used for running calculations in various codes and putting together constituents
of interaction energy and similar quantities. Aside from this functionality, it has
available options for geometry manipulations, which were used in fragmentation
of complexes into PLF547 dataset in Dataset part, and options for parameter
optimization, used for the COSMO2 development. All the calculations, frag-
mentation into constituents of PLF547 dataset, addition of hydrogen atoms to
truncated residues and optimization of parameters with respect to RMSE (Root
Mean Square Error, a measure of deviation) were done in cuby4 framework.
4 Reparametrized COSMO Solvation Model with
a Nonpolar Term – COSMO2
This part of the thesis, COSMO2 part, is dedicated to the optimization of a
COSMO solvation model applied along with the PM6 or PM7 methods. The
motivation behind this undertaking is the development of an SQM scoring func-
tion utilizing a solvation model (COSMO) for in silico drug design [42, 53, 95].
As will be elaborated in dedicated sections, the error in interaction energy pro-
duced by SQM methods is smaller in magnitude than the solvation energy error
of COSMO (solvent models in general). Thereby, when using SQM together
with solvent model to estimate a score of a compound, it is advantageous to fo-
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cus preferentially on the optimization of the solvent model – accuracy limiting
part of the score.
4.1 Strategy of COSMO2 Development
In the work we present here, we have included a nonpolar term to the solvation
energy expression of COSMO model as a total cavity surface A scaled by a
surface tension coefficient ξ
Enp = ξA (EQ.31)
This nonpolar term should cover in average way other than electrostatic con-
tributions to the solvation energy (dispersion, repulsion and cavitation energy).
Additionally, we have optimized the parameters for atomic radii used for
the COSMO cavity construction. The optimization of parameters and surface
tension parameter was performed for PM6 and PM7 SQM methods with respect
to a reference dataset obtained with permission from Truhlar and coworkers [96].
We tested the newly optimized methods along with other solvation models on
independent datasets as well as on actual protein ligand complexes (as a part
of a scoring function).
4.2 Training and Validation Sets for COSMO2 Parametriza-
tion
The training dataset prepared from the data of Truhlar et. al., Minnesota Sol-
vation Database [96], contains geometries and experimental solvation energies
of mostly small molecules in various solvents from which we used water. We
excluded 7 compounds for which the calculations did not converge by some
of tested/benchmark methods. Further, we excluded 57 compounds that were
part of one of the testing data sets (SAMPL1, see below). The resultant training
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data set prepared from Minnesota Solvation Database (MNSol) containing 331
neutral and 138 charged compounds will be denoted MNSol*. The authors of
the original COSMO model used only neutral compounds, when the parameters
were optimized in the later implementations [82, 83]. Detailed list of compounds
in training data set has been provided in supplementary material of ref. [56]. For
the testing of methods we prepared three non-overlapping datasets of neutral
compounds – datasets prepared from data of two SAMPL challenges designated
SAMPL1 [97] and SAMPL4 [98] in this work, a dataset derived from data col-
lected by Mobley et. al. [99] (Mobley266) and one small set of charged species
from Lee et. al. [100] (C10). The SAMPL challenge 1 and 4 provides experi-
mental solvation data for compounds which we had to build and optimize with
the B3LYP-D3/def2-QZVP and with COSMO solvation model. The SAMPL
compounds include herbicides, pesticides or other bioactive small compounds
and are thus drug design relevant. We excluded compounds (10 from SAMPL1
challenge, 6 from SAMPL4) for which experimentally supplied and COSMO-RS
calculated solvation energy differed significantly. This has been done to elimi-
nate possible errors due to selection of conformers. We removed few compounds
of SAMPL4 which were in the training dataset (SAMPL1 has been removed
from the training dataset, so there was no longer any overlap). SAMPL1 and
SAMPL4 derived datasets ended up with 53 and 42 molecules respectively. The
C10 compounds were prepared and optimized as in case of SAMPL. The data
adapted from Mobley et. al. included geometries. After excluding compounds
shared with the training set, 266 small organic molecules remained. Moreover,
we tested the newly parametrized method as a constituent of a SQM scoring
function on a series of complexes of carbonic anhydrase II with 10 compounds,
for which the experimental affinities and structures of complexes were deter-
mined [95]. We then assessed the efficacy of the model on a basis of correlation
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between computed score and an experimental affinity.
4.3 Optimization of COSMO2 Parameters
For the optimization of element radii and the nonpolar term, we used iterative
Broyden–Fletcher–Goldfarb–Shanno numerical gradient-based algorithm. The
starting values for element radii in our considerations were the values found
for the original COSMO implementation in MOPAC (section 3.5.1, Tab. 1).
The starting value for the surface tension parameter was chosen to be 0.05
kcal/mol/Å2. Many runs with different initial parameters were performed to
confirm the minimum found was not only the local one. Firstly, we parametrized
only radii for H, C, N, O elements with the surface tension parameter of non-
polar term by excluding compounds with other elements. Then, we included all
the elements – compounds with S, P, F, Cl, Br, I, but kept H, C, N, O radii
fixed. We focused on these elements for drug design application in mind, since
they are overwhelmingly most common constituents of proteins and their lig-
ands (pharmaceutics). In the COSMO2 publication (reference [56]), radii from
the original COSMO implementation in MOPAC, which were used also as the
starting parameters for our reparametrization, were accidentally listed as for
COSMO, rather than those of the latest version (parametrized ones, which were
actually used in the calculations).
The radius of the hydrogen was significantly reduced by the optimization,
while other radii became larger (Tab. 1). The PM6/COSMO2 optimization
without the nonpolar term yielded about 0.8 kcal/mol greater RMSE result
(compared to the 2.65 kcal/mol, Tab. 2), so its inclusion is significant.
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Table 1: The atomic radii (in Ångstroms) used in the COSMO implementation
in MOPAC, the starting parameters for our reparametrization and the newly
optimized COSMO2 parameters for PM6 and PM7. The effective surface tension
parameter ξ (kcal/mol/Å2).
COSMO Startpoint PM6/COSMO2 PM7/COSMO2
H 1.30 1.08 0.828 0.929
C 2.00 1.53 1.821 1.699
N 1.83 1.48 1.904 1.913
O 1.72 1.36 1.682 1.686
P 2.13 1.75 2.118 2.242
S 2.16 1.70 2.369 2.346
F 1.72 1.3 1.602 1.528
Cl 2.05 1.65 1.911 1.901
Br 2.16 1.8 2.178 2.211
I 2.32 2.05 2.276 2.062
ξ — 0.05 0.046 0.042
Table 2: Errors in solvation free energies (as RMSE relative to the experimental
values, in kcal/mol) in the training set (MNSol*) and four validation sets. C-
PCM’ denotes the C-PCM model excluding the default cavitation and dispersion
terms.
Methods MNSol* Mobley266 SAMPL1 SAMPL4 C10
PM6/COSMO2 2.65 2.81 5.08 2.44 2.18
PM6/COSMO 4.31 3.72 9.07 4.01 2.88
PM6/PCM 6.35 2.24 3.93 1.92 8.38
PM6/SMD 4.80 3.03 4.91 2.59 8.39
PM7/COSMO2 2.62 2.54 3.73 1.92 2.28
PM7/COSMO 3.96 3.44 6.07 3.21 2.87
AM1/COSMO 4.80 2.26 8.89 2.26 4.68
DFTB3/C-PCM 9.92 6.40 12.87 8.96 12.55
DFTB3/C-PCM’ 6.16 2.31 3.66 2.84 8.01
DFTB3/SMD 4.86 2.65 4.85 3.15 5.57
DFT/COSMO-RS 2.54 1.08 1.88 1.59 3.57
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4.4 Results
4.4.1 Performance on Datasets of Small Molecules
We included a higher-level DFT-D3/COSMO-RS for the comparison to sol-
vation models used with SQM methods. Interestingly, the COSMO-RS was
outperformed by some of the simpler solvation models for charged species (Tab.
2, the C10 is composed of ions and the training dataset MNSol* includes ions –
Fig. 3). The optimization of atomic radii parameters with the newly included
nonpolar term for PM6 and PM7 alike did consistently increase the accuracy
of the COSMO(2) model across the datasets (Tab. 2). PM7/COSMO had
been slightly more accurate than PM6/COSMO before the COSMO2 optimiza-
tion and PM7/COSMO2 was still more accurate than PM6/COSMO2 after the
optimization. PM7/COSMO2 was among the most accurate method/model
combinations tested overall. Some SQM methods delivered slightly better es-
timates than PM7/COSMO2, but not consistently throughout the datasets –
especially for datasets with charged species does PM7/COSMO2 (followed by
PM6/COSMO2) best of tested methods. This is understandable, since ions
compose a significant portion of the training dataset. The error reduction upon
COSMO2 optimization is largest for cations (Fig. 3). Interestingly, the improve-
ment of the COSMO2 optimization was the most prominent for the SAMPL1,
neutral dataset. Several compounds of SAMPL1 which produced a very large
deviation (overly negative energies) for most models tested, often contained
phosphorodithioic or other thio-phosphate containing groups. Errors for these
compounds were significantly reduced by the COSMO2 optimization, too.
PM6/PCM was surprisingly accurate for datasets without charged species.
Together with the COSMO2 parametrization for the PM7, it was the best per-
forming SQM-paired solvation model for those datasets, despite the nonpolar
terms are not included in this implementation. As it has been argued in the
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Figure 3: The accuracy of SQM methods combined with solvation models (and
QM DFT paired with COSMO-RS) tested on the COSMO2 training dataset
MNSol* (in RMSE, kcal/mol), the dataset is separated into groups by the com-
pound charge.
COSMO2 publication (reference [56]), the reason for this could be the error
compensation between missing polarization in the SQM method (i.e. missing
stabilization of a system) and missing cavitation and repulsion positive terms
in the solvation model (i.e. missing destabilization of a system). To further this
argument, C-PCM without nonpolar terms (C-PCM’) with DFTB3 in GAMESS
delivered more accurate estimates than with those terms included (2) - the dif-
ference was most significant for neutral compounds. In these cases, reduction of
mean signed error (a measure of systematic deviation) from overly positive val-
ues, goes indeed hand in hand with reduction of RMSE upon turning nonpolar
terms off.
SMD model is comparable to PCM, but is not originally developed for
SQM calculations. Despite of the nonpolar term inclusion, PM6/SMD (GAUS-
SIAN) performed worse than PM6/PCM (GAUSSIAN) except for MNSol*,
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which nearly coincided with the training set for the SMD development, and
C10 with ions. Similarly, DFTB3/SMD in GAMESS did worse than C-PCM’
without nonpolar terms in some of tested datasets. Although the authors of the
SMD model highlighted the portability of the model among electronic struc-
ture methods [86], clearly, this can result in a loss of accuracy. We recommend
method-specific parametrization and thus from this point of view, high-quality
benchmark datasets are of crucial importance.
4.4.2 Performance on Large Protein-Ligand Complexes
We ultimately aim for the application in drug design, on complexes of proteins
and pharmaceutics. Thus we tested the newly parametrized method embed-
ded in a scoring function on 10 complexes of a carbonic anhydrase II with a
sulfoamide-containing analogues [95]. Since the experimental affinities of the
complexes are know, we correlated these with the calculated interaction ener-
gies in the solvent. These were expressed by the scoring function as a sum of two
terms – a change of energy upon the protein-ligand complex formation in the
vacuum (calculated by a SQM method) and a change of solvation energy upon
the complex formation (achieved with the PM6 or PM7 SQM method paired
with a solvation model).
score = ∆Eint +∆∆Gsolv. (EQ.32)
For these particular high-resolution structures, position of water molecules
are known. As those may somehow interfere with the implicit solvent models
and are usually not attainable, we provide corresponding results for structures
with water molecules removed (Fig. 5).
Although PM7/COSMO2 in this experimental setup did not consistently
outperform PM6/COSMO2 (PM6-D3H4/COSMO2 is slightly more accurate
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Figure 4: Carbonic anhydrase II (PDB code: 3PO6) [101] with a sulfonamide
containing ligand.
than PM7/COSMO2 for complexes without explicit water molecules), COSMO2
reparametrization either way increased the correlation between the score and
the experiment, more so for the complexes without the explicit water molecules
(Fig. 5).
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Figure 5: Coefficient of determination (R2) in the series of carbonic anhydrase II
inhibitors for scoring functions combining different methods for the calculation
of gas-phase interaction energy (∆Eint) and the solvation interaction energy
(∆∆Gsolv). Results obtained with and without explicit structural waters are
listed.
5 The Development of Protein-Ligand Derived
Benchmark Datasets
This "Dataset" part presents the development of PLF547 (Protein Ligand Frag-
ment, 547 complexes) and PLA15 (Protein Ligand Active site, 15 complexes)
datasets with benchmark reference interaction energies and solvation energies
computed on high computational levels.
Surprisingly, not many databases or datasets are devoted to protein-ligand
systems. There are several dataset of interacting small organic molecules [71,
102] and there is a protein-ligand derived dataset [103], which is, however, lim-
ited in its size and variability (one ligand and its fragmented protein environ-
ment). Recently a large GMTKN55 [104] multi-purpose dataset containing also
PCONF21 [105] dataset with high-level QM conformational energies of amino-
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acid oligomers has been published. A MPCONF196 dataset includes also con-
formers of several larger macrocycles (representing common ligands, but with-
out sulfur, phosphorus or halogen atoms) [78]. An argument was made in the
COSMO2 part for the need of good-quality reference data serving the develop-
ment of SQM methods (or solvation models).
Here, we pursue this motivation further by constructing large datasets for
noncovalent interactions devoted specifically to protein-ligand complexes and
derived systems with the aim of testing and development of SQM methods for in
silico drug design. Any semiempirical parameters or corrections for SQM meth-
ods obtained on these datasets should then be well suited for the description of
systems relevant to in silico drug design, biochemistry and related applications.
5.1 The Complexes Constituting the Datasets
The complexes of the two datasets devised were based on structures which we
obtained from reference [32]. These are the structures of 17 medically relevant
protein-ligand complexes of several protein families with a resolution below 2.5
Å taken originally from the Protein Data Bank. The preparation of structures
done earlier (ref. [32]) included removal of crystal waters, protonation (addition
of hydrogen atoms) and disulfide bond assignment. Ligands are up to 100 atoms
in size, with charge of 0, +1 or -1, all contain aromatic rings, some of them sulfur
and some are halogenated (Fig. 6).
The PLA15 consists of 15 ligands interacting with its protein surroundings,
amino acids up to 4 Å apart (Fig. 7). Two of 17 complexes were excluded
because reliable benchmark data were not achieved due to the self interaction
error (see below) as a DFT is used as a basis of the reference benchmark (sections
3.4, 3.5.2). Additional two amino acid residues were excluded from the selection
due to intermolecular clashes (tyrosine 139 of 2YKI and lysine 98 of 2VW5).
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Figure 6: Ligands of protein structures from which the datasets were prepared.
PDB codes are listed. 3GCU and 3JVS were excluded from the PLA15 dataset
due to large self-interaction error (as discussed in section 5.2.1). Figure taken
from ref. [32].
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PLF547 consists of complexes of the same 17 ligands interacting with each
protein fragment (backbone or amino acid side chain) within 4 Å of the re-
spective ligand at once (Fig. 8). Two fragments corresponding to residues
removed from PLA15 due to steric clashes were also excluded from PLF547. In
other words, the protein part from PLA15 (and also from the two of original
17 active site-ligand complexes not included in PLA15) have been fragmented
to individual amino acids or backbone parts, each one forming a complex with
its respective ligand. Bonds between carbonyl and Cα as well as between Cα
and Cβ (except for proline, glycine) carbons atoms were truncated and ter-
minated with hydrogen atoms, yielding N-methylformamide (backbone model)
or side chain models, respectively. This fragmentation ultimately yielded 547
complexes of protein fragments interacting with their respective ligands. The
benchmark interaction energy values have been calculated by composite schemes
of QM methods. For benchmark solvation energies, we used DFT/COSMO-RS.
Out of the remaining complexes, 8 additional fragments most affected by the
self interaction error were excluded from the analysis of solvation interaction
energies, since our benchmark to those is DFT based (DFT/COSMO-RS). The
datasets were provided as supplementary material of publication in reference
[23]. The performance of SQM methods on the newly devised dataset hinted at
avenues of future improvement or cases when caution is due.
Trends in the accuracy of methods tested on the PLF547 dataset have been
analyzed by separating its constituents into 4 subsets by the distance between
interacting partners (below 90 % of the van der Waals radii sum of closest atoms
– short, 90-110 – equilibrium, 110-130 – long and above 130 % – distant), 3 sub-
sets by the total charges of interacting partners (both charged, one neutral, both
neutral) and into 6 subsets by the type of protein residue fragments (backbone
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– N-methylformamide; aromatic – His, Trp, Phe, Tyr; other nonpolar – Ala,
Val, Ile, Leu, Met; polar – Ser, Thr, Asn, Gln, Cys, Pro; anion – Glu, Asp and
cation – Arg, Lys, protonated His).
Figure 7: A complex derived from 3JVS Protein Data Bank structure, one of
the PLA15 active site complexes. Carbon atoms of a protein part in green, of a
ligand in black.
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Figure 8: One of the PLF547 fragment complexes derived from 3JVS.
5.2 Results
5.2.1 PLF547, Interaction Energies
Here we present the accuracy in interaction energy estimates of selected SQM
and QM methods on the PLF547 dataset grouped by the distance between
interacting partners (Fig. 9), by the type of a protein fragment (Tab. 3) and
by the total charge of interacting moieties and overall (Fig. 10).
Trends in Accuracy for the Complexes Grouped by the Distance of
Interacting Partners We have found out that DFT and DFTB methods
provided large errors (interaction overestimation) for several systems that con-
tained a charged protein fragments further away from the ligand (Fig. 9, equi-
librium, long and distant separations). This is contrary to expectation that the
error should become smaller with the increasing separations, since the absolute
magnitude of interaction is smaller. We have attributed this coounterintuitive
results to the self-interaction error (SIE) of the DFT approach, when the density
52
interacts with itself unphysically.
Figure 9: The error of methods on PLF547 complexes divided into groups by
interacting partner separation. Even though the overall error decreases with
the separation, several outliers with large errors emerge. Notably, this is true
for the DFT and DFTB methods. Even AM1 – the least accurate of SQM
methods presented here (Tab. 10), is not encumbered by such outliers on greater
separations.
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Table 3: The RMSE of the methods tested on the PLF547 dataset, in kcal/mol.
Complexes sorted by the type of the protein fragment.
Methods Backbone Aromatic Nonpolar Polar Anion Cation
MP2/aug-cc-pVDZ 0.27 0.65 0.27 0.48 1.05 0.59
B3LYP-D3/QZVP 0.26 0.45 0.22 0.35 1.68 0.80
BLYP-D3/QZVP 0.30 0.50 0.24 0.36 4.97 3.31
BLYP-D3/DZVP 0.41 0.72 0.25 0.58 6.31 1.56
AM1 2.61 5.72 2.64 4.50 12.30 4.96
PM6 1.44 3.47 1.92 2.37 6.38 4.18
PM6-D3H4 0.73 1.33 0.40 1.47 2.13 1.89
PM7 1.41 2.58 0.90 1.88 3.00 3.65
DFTB3-D3H4 0.66 1.15 0.39 1.45 4.89 2.86
DFTB3-D3H5 0.61 1.12 0.40 1.05 4.10 2.55
GFT2-xTB 0.63 1.31 0.46 0.93 6.88 3.63
HF-3C 0.84 1.69 1.99 2.32 7.40 2.44
Trends in Accuracy for the Complexes Grouped by the Protein Frag-
ment Type Although less apparent than the self-interaction error of DFT-
based methods, a few trends seem noticeable in the error distribution in systems
separated by the kinds of protein fragments. Firstly, aromatic systems seem to
have rather big error, comparable to that of ions, even though absolute inter-
action energies among ions are much larger (Tab. 3). For example, for AM1,
interaction involving aromatic protein residue have even slightly bigger RMSE
than those involving cations. Additionally, HF-3C seems to overestimate in-
teraction involving sulfur and likely also interactions with halogenated ligands.
For anion-fragment complexes, HF-3C (GFN2-xTB and some other methods
to lesser extent) provide larger error caused by a slight overestimation of in-
teraction of several systems, while the cationic complexes are described better.
Relatively larger error of PM7 for "nonpolar" and "backbone" complexes may
be due to the inaccurate description of hydrogen bonds.
The Accuracy for the Complexes Grouped by the Net Charges and
Overall Out of QM methods, MP2 results (also used for the benchmark) and
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B3LYP DFT are very accurate with RMSE 1 kcal/mol for the interaction be-
tween charged systems and about 0.25 kcal/mol for neutral ones (Fig. 10). The
error of the non-hybrid BLYP DFT functional (with two basis sets) is signifi-
cantly higher for other than neutral systems - higher than the error obtained
with some of SQM methods. This error of non-hybrid functionals is caused by
the SIE (which is apparent from Fig. 9 for larger separations). Observed depen-
dencies on the functional and on separation can be found in the literature [106,
107]. Overall, PM6-D3H4 provided the most accurate results for SQM methods,
Figure 10: The root mean square error (RMSE) in the interaction energy esti-
mates given by the tested methods on the PLF547 fragment data set relative to
the benchmark. Four columns represent complexes divided into groups where
both interaction partners are ions (red), one neutral, one ion (yellow) or both
neutral (gray). Blue column is an overall RMSE for all the 547 fragments. MP2
had been calculated in aug-cc-pVDZ basis. In the DFT calculations, QZPV
stands for def2-QZVP and DZVP for DZVP-DFT basis sets, respectively.
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judging by its RMSE, with DFTB3-D3H4 and DFTB3-D3H5 following (Fig. 10,
blue columns). Without the 8 systems with the large SIE (which were removed
from the solvation interaction energy analysis, section 5.1), all the DFT-based
SQM methods yield better results and DFTB-D3H5 becomes the most accurate,
slightly more so than PM6-D3H4 (both methods yielding about 1.1 kcal/mol
RMSE in this setup). PM7, GFN2-xTB and HF-3C were the least accurate,
however without the 8 SIE outlier systems, GFN2-xTB performs better (about
1.35 kcal/mol RMSE as compared to 2.1, Fig. 10). GFN2-xTB is also the most
accurate SQM method for neutral-neutral type complexes (which were also less
affected by the SIE error, Fig. 10). PM7 overestimates the interaction slightly
(Fig. 9), likely due to overly attractive dispersion term [108].
5.2.2 PLF547, Solvation Interaction Energies
Here we describe the performance of the selected solvation models used with
SQM methods in terms of solvation interaction energy accuracy compared to
DFT/COSMO-RS. The 8 self-interaction error systems have been removed,
since the reference benchmark is DFT-based. We include another QM-based
solvation model HF/6-31G*/SMD. The important notion is, that COSMO-RS
solvation model is not as reliable benchmark for solvation energy as the corre-
lated QM methods for interaction energy are. It is thereby necessary to be cau-
tious about the results presented in this section. The same applies for PLA15
solvation energy references composed of these COSMO-RS benchmark values
presented further on (section 5.2.4). For example, QM-based HF/SMD gave
comparable results to SQM methods. But given the estimated benchmark er-
ror is comparable to errors provided by the tested methods, the results may be
much different when compared to the "true" solvation energy, which is inacces-
sible. As we have shown in COSMO2 part, COSMO-RS gives about 1 kcal/mol
RMSE with respect to experimental solvation energies for neutral compounds
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Table 4: The RMSE of the energy change upon the formation of the fragment–
ligand complex in kcal/mol on the PLF547 complexes for the combinations of
SQM or QM methods and solvation models tested. The results listed overall
and grouped by the net charge of interacting partners.
Methods Ion-Ion Ion-Neutral Neutral-Neutral All
HF/6-31G*/SMD 4.67 2.29 1.25 2.21
PM6/COSMO 6.06 2.11 1.26 2.35
PM6/COSMO2 4.18 1.83 1.24 1.89
PM7/COSMO 5.83 2.03 1.26 2.27
PM7/COSMO2 4.31 1.82 1.25 1.91
DFTB3/SMD 4.29 2.02 1.08 1.97
DFTB3/PCM 8.0 3.43 3.27 3.87
(3) – already comparable with the error SQM and HF/SMD methods provide
here, with respect to COSMO-RS for neutral compounds (Tab. 4).
With the above noted precaution in mind, all these methods give similarly
accurate estimates, aside from DFTB/C-PCM, which was off the mark for either
neutral and charged systems, as well. This is consistent with the results in
the COSMO2 part, where the method performed poorly, too. The effect of
exaggerated "repulsion" is indicated by a positive and significant mean signed
error (2.3 as opposed to below 0.5 kcal/mol from other methods). Without the
nonpolar terms, the methods improve the accuracy by about 1 kcal/mol RMSE
(from 3.8 to 2.8), while mean signed error drops to -0.8 (now, in an opposite
direction – slight overestimation). There seems to be an imbalance in nonpolar
terms of the PCM implementations in GAMESS. COSMO2 seems to be an
improvement over COSMO in this setup, too. Again, the difference is apparent
for charged systems.
5.2.3 PLA15, Interaction Energies
In this section, the errors of interaction energies on ligands complexed with their
respective protein surroundings (PLA15) obtained by selected SQM methods
are provided. The PLA15 complexes are designed to represent faithfully the
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protein-ligand interaction. These results are thus of immediate significance for
drug design.
In the presented comparison we exclude HF-3C and most of other QM meth-
ods due to size of the systems. The QM BLYP/DZVP-DFT interaction energies,
as have been used for the calculation of the PLA15 benchmark (Methods, sec-
tion. EQ.26), are shown for the comparison with SQM methods. We discuss the
errors in % of kcal/mol relative to the benchmark values (Tab. 5, "benchmark"
column).
AM1 and PM6 methods without semiempirical corrections underestimated
the interaction for all the complexes, with the average error 55% of the bench-
mark interaction energy (Tab. 5). Clearly, errors of this magnitude are un-
acceptable. PM7 showed an improvement over AM1 and PM6 (for PM7 the
interaction is overestimated, AM1 and PM6 underestimate it), but was outper-
formed by all the other SQM methods. Other SQM methods – PM6-D3H4,
DFTB2-D3H4, DFTB3-D3H5 and GFN2-xTB – the most accurate of them,
are roughly comparable, with the error about 10% of a total interaction energy.
The performance of these SQM methods is comparable to that of BLYP/DZVP-
DFT. Interestingly, out of these methods, only GFN2-xTB underestimated the
interaction. A systematic shift in error is apparent for the methods. Such a
behaviour can be easily corrected for. Moreover, in in silico drug design often
only the relative values are of importance, since systematic deviation cancels
out when comparing predictions given by a single method for multiple systems.
When the average deviation is subtracted, we obtain a random, nonsystematic
part of an error (Tab. 5, absolute random error). For this setup, DFTB3-D3H5































































































































































































































































































































































































































































































































































































































































































































































































5.2.4 PLA15, Solvation Interaction Energies
we show the error (in % of kcal/mol) of selected solvation models relative to
the benchmark on PLA15 dataset. We took the reference interaction energies
in the solvent as a sum of COSMO-RS energies for the fragments constituting
the respective active site. This approach neglects any nonlinear (polarization
related) effect altogether, however, any better solvation (interaction) energy
reference for large protein complexes would be hard to achieve. All the methods
tested were calculated in this setup.
HF/SMD overestimated the interaction in solvent significantly and system-
atically – for all the complexes, compared to the COSMO-RS reference. Most
notably, DFTB3/C-PCM produced very large errors, especially for the neutral
ligands (Tab. 6). Upon closer inspection, this error is generated by the summing
up of interaction energies of fragments that are systematically shifted to posi-
tive values (interaction underestimation). Since the approximate benchmark for
PLA15 solvation is a mere sum of COSMO-RS solvation energies of fragments,
the systematic underestimation is more apparent in this setup. For charged
ligands (at least one of the partners is an ion), the effect is less apparent. Here,
COSMO2 seems to be slightly more accurate than respective COSMO variants,






























































































































































































































































































































































































































































































































































































































































































































































In the COSMO2 part, we have shown that one can achieve a reasonable accuracy
improvement of a solvation model by means of relatively simple optimization.
Changes to the underlying COSMO included reparametrization of parameters
for element radii and addition of a function containing an extra parameter. In
this way, the method can still resolve large systems very quickly – COSMO2 can
readily be used along with MOZYME in MOPAC, and in this way, the energy of
a 1000 atom system takes about 2 minutes to calculate). Solvation energies are
larger for ionic species, and solvation energy estimates of solvation methods are
correspondingly large for ionic species. However, when training dataset includes
charged moieties, the parametrization can absorb a substantial amount of this
error, as we have seen for the COSMO2 datasets. Newly parametrized methods
outperformed even more elaborate COSMO-RS/DFT for charged species.
The accuracy of solvation models depends strongly on how and with which
SQM method the model is implemented. We have attained better results for
DFTB3 without the default nonpolar term than when we included it (likely
due to error cancellation). When using solvation models, it appears that the
efficacy of various parametrizations for concrete SQM methods may not be fully
transferable among various implementations.
These results stress the significance of a robust and encompassing datasets.
6.2 PLF547/PLA15 Datasets
For the development of datasets for noncovalent interactions, PLF547 and PLA15,
our task was simpler in a way that for (interaction) energies, there are high-level
QM approaches which are trusted enough to provide energy estimates close to
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true experimental energies. On the other hand, this is not the case for solvation
models. In this work, we used MP2 and CCSD(T)-DLPNO to produce accurate
reference data of interaction energies for small 547 systems. For a dataset of
whole 15 active site models, we introduced an approximation, to get as close to
reliable energy estimates as possible. Our subsequent study of SQM methods
on the new datasets showed that both PM6 and DFTB3 with D3H4 (or D3H5)
corrections yielded very accurate interaction energy estimates, advocating the
effectiveness of empirical corrections. We show that SQM methods with em-
pirical corrections can provide results of accuracy approaching those of DFT
methods on the complexes studied. Furthermore, we have discovered some er-
ror trends specific to a SQM method for specific system types. For instance, we
have encountered a density self-interaction error produced by DFT and DFT-
based SQM methods when applied to several complexes of developed datasets.
The error of these systems had a significant effect on a statistical analysis of
method accuracy. Although these seem to be functional-dependent (in case of
DFT) regarding their magnitude, the methods reproduce the error consistently
for these specific systems (for which other methods provide relatively accurate
estimates). Some other weaker trends were also noticeable for some of SQM
methods.
With a better knowledge of weak sides of concrete SQM methods, caution is
due when using them on high-risk systems until semiempirical corrections are
devised to cover them.
When considering the results of both parts of this work together, the absolute
errors in estimates of solvation energies with solvation models currently in use
are larger that the errors of interaction energies of comparable SQM methods
(comparing COSMO2 results to interaction energy accuracy of SQM methods
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tested in the Dataset part). For the purpose of in silico drug design, it is
thereby advantageous to focus preferentially on the accuracy of solvation energy
estimation, since it has the same impact on the overall score, ligand binding
affinity prediction, as the interaction energy does. In the Dataset part, where
we used DFT/COSMO-RS as a reference for a solvation energy part of the
study, COSMO2 seems to outperform standard COSMO for charged species,
confirming the observations made in the COSMO2 part.
7 Future Perspectives
Regarding COSMO2, preliminary results indicate, that it is possible to improve
on the model further by implementing parameters for an atom in a specific
environment (group). It seems like some molecular groups produce larger solva-
tion energy error than others, as indicated by a large error spread in SAMPL1
dataset. The dependence on valence state has been observed for parameters
for dispersion correction [9]. Arguably, implementing different atom types for
solvation models would be computationally inexpensive way to improve the ac-
curacy. The nonpolar term can likewise be improved by using atom-type specific
surface, as in case of SMD nonpolar term. The inclusion of the COSMO2 in the
scoring function developed in our group is being tested.
The work on additional dataset of small organic moieties is already in progress
designed to introduce corrections to SQM methods for specific interactions. The
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